Charting
the Future of
Biotechnology
Charting
the Future of
Biotechnology
Congress charged the National Security Commission on Emerging Biotechnology with conducting a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future activities of the Department of Defense.
Mission
Congress charged the National Security Commission on Emerging Biotechnology with the responsibility of examining the critical intersection of emerging biotechnology and national security. When Congress created the Commission, it defined the Commission’s formal mandate as conducting a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future national defense activities, including activities of the Department of Defense. The Commission will submit its comprehensive report to Congress in December 2024, which will include policy recommendations that respond to our mandate. The work of the Commission will continue through June 2026 as we work to educate and expand upon our recommendations.
Commissioners
The Commission is comprised of twelve appointed members. Commissioners were selected by a bipartisan, bicameral group of Members of the House and Senate, including the Speaker of the House, House Minority Leader, Senate Majority Leader, Senate Minority Leader, and leadership of the House and Senate Armed Services Committees.
Chair
Vice Chair
About Us
Congress charged the National Security Commission on Emerging Biotechnology with conducting a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future activities of the Department of Defense.
The Commission is a legislative branch advisory entity and is expected to provide an interim report to the President and the Armed Services Committees in December 2023 and submit a final, unclassified report in December 2024, including recommendations for action by Congress and the federal government.
If you have ideas to share or would like to contribute to the work of the Commission, please email us at ideas@biotech.senate.gov.
Careers
We welcome applicants for all positions with a strong work ethic, ability to work both independently and as part of a team, and an ability to manage multiple work streams with competing timelines. The Commission is an equal-opportunity employer.
To apply
Send an email to jobs@biotech.senate.gov with the following information:
Email Subject
Position Name [Your Last Name]
Body of Email
Include the following:
- Desired Start Date
- Salary Requirements (optional)
- Tell us in no more than 300 words why you are the right fit to join the Commission staff
- Attach your current resume
Open Positions
Detailee
The National Security Commission on Emerging Biotechnology seeks experienced current Federal employees for Detailee positions with the Commission’s policy and research team. Responsibilities may include research and policy development for legislative and executive action; engaging with stakeholders including other government agencies and non-government entities; drafting and editing memos, reports, and other written products; and collaborating with other Commission staff to execute on Commissioner-driven ideas and requests. Ideal candidates will have expertise relevant to biotechnology, biomanufacturing, or other emerging technologies; excellent verbal and written communication skills; experience working as part of a multi-disciplinary team; strong interpersonal, organizational, and planning skills; and the ability to adapt to a fast-paced environment.
Policy Analyst or Policy Advisor
The National Security Commission on Emerging Biotechnology seeks a Policy Analyst or Policy Advisor to work on the Commission’s Policy and Research team. This role will be a blend of administrative, research, and policy development work focused on classified components of the Commission’s reporting mandates. Responsibilities may include cataloging and organizing classified information; developing classified reports and analysis; conducting policy research; engaging with stakeholders including other government agencies; drafting and editing memos and other written products; briefing internal and external audiences; and collaborating with other Commission staff to execute on Commissioner-driven ideas and requests. Ideal candidates will have expertise relevant to national security technology development, including biotechnology or other emerging technologies; excellent verbal and written communication skills; the ability to work independently; experience working as part of a multi-disciplinary team; strong interpersonal, organizational, and planning skills; and the ability to adapt to a fast-paced environment. Candidates must currently hold (or have held within the past two years) an active Top Secret security clearance; ideal candidates will have an active TS/SCI clearance. The expected salary range for this position is $100,000 to $125,000 with eligibility for standard Federal benefits.
Fall Intern
The National Security Commission on Emerging Biotechnology is seeking in person, fall Policy and Operations Interns. This internship will provide an exciting opportunity to gain firsthand knowledge of national security policy related to emerging biotechnology Responsibilities may include research, drafting and editing internal written products, administrative tasks, and other duties as assigned. Ideal applicants will have demonstrated experience or interest and working knowledge in science and technology policy, biology, politics, or national security; excellent verbal and written communication skills; experience working as part of a multi-disciplinary team; strong interpersonal, organizational, and planning skills; and the ability to adapt to a fast-paced environment. This is an unpaid position, but applicants are permitted to accept external funding from other sources. Please include your fall availability when applying for this role.
Contact us
Please fill out the contact form or email us directly at ideas@biotech.senate.gov
For press inquiries please email us at press@biotech.senate.gov
